NO20063134L - Mikrokrystaller og farmasoytiske formuleringer omfattende de samme - Google Patents

Mikrokrystaller og farmasoytiske formuleringer omfattende de samme

Info

Publication number: NO20063134L
Authority: NO; Norway
Prior art keywords: microcrystals; same; pharmaceutical formulations; propaneamide; benzothiepin
Prior art date: 2003-12-11

Application number

NO20063134A

Other languages

English (en)

Norwegian (no)

Inventor

Norie Satoh

Naoto Izawa

Nobuhiro Yagi

Kazue Ouchi

Shoichi Narita

Noboru Aoki

Original Assignee

Kyowa Hakko Kogyo Kk

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2003-12-11

Filing date

2006-07-06

Publication date

2006-09-08

2006-07-06 Application filed by Kyowa Hakko Kogyo Kk filed Critical Kyowa Hakko Kogyo Kk

2006-09-08 Publication of NO20063134L publication Critical patent/NO20063134L/no

Links

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
- C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D495/04—Ortho-condensed systems
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/10—Drugs for disorders of the urinary system of the bladder
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/12—Antidiuretics, e.g. drugs for diabetes insipidus

Landscapes

Organic Chemistry (AREA)
Chemical & Material Sciences (AREA)
Health & Medical Sciences (AREA)
Engineering & Computer Science (AREA)
Medicinal Chemistry (AREA)
Bioinformatics & Cheminformatics (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Pharmacology & Pharmacy (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Urology & Nephrology (AREA)
Diabetes (AREA)
Hematology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicinal Preparation (AREA)
Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
Materials For Medical Uses (AREA)

NO20063134A 2003-12-11 2006-07-06 Mikrokrystaller og farmasoytiske formuleringer omfattende de samme NO20063134L (no)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
JP2003413725		2003-12-11
PCT/JP2004/018773 WO2005056561A1 (ja)	2003-12-11	2004-12-09	微細結晶及びそれを含む医薬製剤

Publications (1)

Publication Number	Publication Date
NO20063134L true NO20063134L (no)	2006-09-08

Family

ID=34675069

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO20063134A NO20063134L (no)	2003-12-11	2006-07-06	Mikrokrystaller og farmasoytiske formuleringer omfattende de samme

Country Status (13)

Country	Link
US (1)	US20070049634A1 (zh)
EP (1)	EP1693374B1 (zh)
JP (1)	JPWO2005056561A1 (zh)
KR (1)	KR20060121163A (zh)
CN (1)	CN1845927A (zh)
AT (1)	ATE411320T1 (zh)
AU (1)	AU2004297132A1 (zh)
CA (1)	CA2550136A1 (zh)
DE (1)	DE602004017220D1 (zh)
ES (1)	ES2314484T3 (zh)
NO (1)	NO20063134L (zh)
TW (1)	TW200522943A (zh)
WO (1)	WO2005056561A1 (zh)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US20190314220A1 (en)	2018-04-11	2019-10-17	The Procter & Gamble Company	Disposable Absorbent Articles

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
JP3283267B2 (ja) *	1997-04-15	2002-05-20	協和醗酵工業株式会社	三環式化合物
WO2000000492A1 (fr) *	1998-06-26	2000-01-06	Chugai Seiyaku Kabushiki Kaisha	DERIVE D'ACIDE L-α-AMINOADIPIQUE EN POUDRE FINE, PREPARATIONS SOLIDES ORALES CONTENANT LEDIT DERIVE ET PROCEDE DE TRAITEMENT DE POUDRES EN VRAC
JP2002053580A (ja) *	2000-08-09	2002-02-19	Kyowa Hakko Kogyo Co Ltd	三環系化合物の製造法
WO2002013823A1 (en) *	2000-08-14	2002-02-21	Teva Pharmaceutical Industries Ltd.	Micronized torsemide
AU2002239504A1 (en) *	2000-12-06	2002-06-18	Pharmacia Corporation	Laboratory scale milling process
CN1498109A (zh) *	2001-03-30	2004-05-19	Э�ͷ��͹�ҵ��ʽ��	膀胱感觉过敏治疗剂
US7354949B2 (en) *	2001-03-30	2008-04-08	Kyowa Hakko Kogyo Co., Ltd.	Therapeutic agent for bladder irritative symptoms associated with benign prostatic hyperplasia
CA2442463A1 (en) *	2001-03-30	2002-10-10	Kyowa Hakko Kogyo Co., Ltd.	Therapeutic agent for overactive bladder
US20040248926A1 (en) *	2001-11-13	2004-12-09	Hayashi Ken-Ichi	Preventive or remedy for pruritus

2004
- 2004-12-03 TW TW093137286A patent/TW200522943A/zh unknown
- 2004-12-09 AU AU2004297132A patent/AU2004297132A1/en not_active Abandoned
- 2004-12-09 KR KR1020067011372A patent/KR20060121163A/ko not_active Application Discontinuation
- 2004-12-09 EP EP04807132A patent/EP1693374B1/en not_active Not-in-force
- 2004-12-09 CN CNA2004800256578A patent/CN1845927A/zh active Pending
- 2004-12-09 AT AT04807132T patent/ATE411320T1/de not_active IP Right Cessation
- 2004-12-09 DE DE602004017220T patent/DE602004017220D1/de not_active Expired - Fee Related
- 2004-12-09 US US10/582,328 patent/US20070049634A1/en not_active Abandoned
- 2004-12-09 WO PCT/JP2004/018773 patent/WO2005056561A1/ja active Application Filing
- 2004-12-09 JP JP2005516247A patent/JPWO2005056561A1/ja not_active Withdrawn
- 2004-12-09 CA CA002550136A patent/CA2550136A1/en not_active Abandoned
- 2004-12-09 ES ES04807132T patent/ES2314484T3/es active Active
2006
- 2006-07-06 NO NO20063134A patent/NO20063134L/no not_active Application Discontinuation

Also Published As

Publication number	Publication date
CA2550136A1 (en)	2005-06-23
US20070049634A1 (en)	2007-03-01
CN1845927A (zh)	2006-10-11
WO2005056561A1 (ja)	2005-06-23
EP1693374A4 (en)	2007-01-03
KR20060121163A (ko)	2006-11-28
EP1693374A1 (en)	2006-08-23
ATE411320T1 (de)	2008-10-15
EP1693374B1 (en)	2008-10-15
ES2314484T3 (es)	2009-03-16
AU2004297132A1 (en)	2005-06-23
TW200522943A (en)	2005-07-16
JPWO2005056561A1 (ja)	2007-07-05
DE602004017220D1 (de)	2008-11-27

Similar Documents

Publication	Publication Date	Title
AU2003211560A1 (en)	2003-09-09	Novel phenylalanine derivative
AU2003247668A1 (en)	2004-02-02	Non-irritating antiperspirant compositions containing acidic antiperspirant active
EP1420829A4 (en)	2006-05-17	IMMUNOMODULATING COMPOSITIONS, FORMULATIONS AND METHOD FOR THEIR USE
AU2002234476A1 (en)	2003-04-03	Medical aerosol formulations
AU2002347910A1 (en)	2003-04-28	Methods and compositions for targeting proteins across the blood brain barrier
AU2003225444A1 (en)	2003-10-13	Oral suspension formulation
HK1087399A1 (en)	2006-10-13	Pharmaceutical formulations comprising highly purebases of 3, 3-giphenylpropylamine monoesters
PT1594544T (pt)	2016-07-14	Composições orais de fenretinida tendo biodisponibilidade aumentada e métodos de utilização das mesmas
WO2002053519A3 (en)	2003-03-13	Hydrophobic polyamine analogs and methods for their use
AU2002248417A1 (en)	2002-09-12	Photoprotecting formulations
ZA200506750B (en)	2007-02-28	Pharmaceutical composition comprising 5-methyl-2-2'-(chloro-6'-fluroanilino) phenylacetic acid
AU2002365647A1 (en)	2003-06-17	Pyridyloxyalkanoic acid amide derivatives useful as fungicides
HK1094152A1 (en)	2007-03-23	Orodispersible pharmaceutical composition of an antithrombotic compound
NO20063134L (no)	2006-09-08	Mikrokrystaller og farmasoytiske formuleringer omfattende de samme
IL160960A0 (en)	2004-08-31	Reduced toxicity cisplatin formulations and methods for using the same
AU2002341145A1 (en)	2003-05-06	Pharmaceutical formulation comprising more than 15% tamoxifen
AU2003216904A1 (en)	2003-10-20	Aqueous formulations of (2-hydroxymethyl-indanyl-4-oxy)-phenyl-4,4,4-trifluorobutane-1-sulfonate
AU2003275360A1 (en)	2004-05-25	Aqueous 2,6-diisopropylphenol pharmaceutical compositions
AU2002255698A1 (en)	2002-09-24	Substituted 3',4'-di-o-camphanoyl-(+)-cis-khellactone analogs,compositions thereof, and methods for using thereof
AU2002339720A1 (en)	2004-01-06	Improved pharmaceutical dental formulations
AU2003303923A1 (en)	2004-09-06	Oral care composition comprising an antimicrobial agent
AU2002953460A0 (en)	2003-01-09	Dental formulation
AU2003281920A1 (en)	2004-04-23	Target-oriented formulations
WO2003069998A8 (en)	2003-12-04	Stable compositions comprising tezacitabine
AU2003296031A1 (en)	2004-06-23	Tatiana abacumov's express-design-workshop method

Legal Events

Date	Code	Title	Description
2009-07-27	FC2A	Withdrawal, rejection or dismissal of laid open patent application